Chembio Diagnostics Inc (CEMI) Stock: Do Analysts Think You Should Buy?

Tuesday, August 10, 2021 01:58 PM | InvestorsObserver Analysts

Mentioned in this article

Chembio Diagnostics Inc (CEMI) Stock: Do Analysts Think You Should Buy?

Wall Street is positive on Chembio Diagnostics Inc (CEMI). On average, analysts give Chembio Diagnostics Inc a Buy rating. The average price target is $10, which means analysts expect the stock to climb by 250.88% over the next twelve months. That average ranking earns Chembio Diagnostics Inc an Analyst Rating of 29, which is better than 29% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating CEMI a Buy today. Find out what this means to you and get the rest of the rankings on CEMI!

See Full CEMI Report

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions **before** a quarterly report that could be worse than expected. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Chembio Diagnostics Inc Stock Today?

Chembio Diagnostics Inc (CEMI) stock is down -4.53% while the S&P 500 is up 0.17% as of 1:52 PM on Tuesday, Aug 10. CEMI is lower by -$0.13 from the previous closing price of $2.98 on volume of 2,524,275 shares. Over the past year the S&P 500 has risen 32.13% while CEMI is lower by -49.91%. CEMI lost -$1.30 per share the over the last 12 months. Click Here to get the full Stock Report for Chembio Diagnostics Inc stock.